Adipose tissue plays an important role in energy balance and metabolism and is the major target for insulin-sensitizing peroxi-some proliferator-activated receptor (PPAR) agonists. The an-giotensin II type 1 receptor blocker telmisartan, a partial agonist of PPAR-, has been demonstrated to improve insulin sensitivity. However, there is uncertainty about the sites of its action. Here, we demonstrate that treatment with telmisartan (3 mg/kg p.o.) for 7 weeks decreased plasma glucose levels in oral glucose and insulin tolerance tests and the index of the homeostasis model assessment of insulin resistance in A-ZIP/F-1 transgenic mice, an animal model of lipodystrophy. These effects were accompanied by decreases in circulating triglyceride and...
Abstract Background Metabolic syndrome is a cluster of common cardiovascular risk factors that inclu...
In the present study, we examined the therapeutic effects of olmesartan, an angiotensin II (Ang II) ...
Hypertension and dyslipidemia are two major risk factors for cardiovascular diseases and commonly oc...
Adipose tissue plays an important role in energy balance and metabolism and is the major target for ...
Glitazones are peroxisome proliferator-activated receptor (PPAR)-gamma agonists with powerful insuli...
AbstractEvidence has accumulated that some of the angiotensin II AT1 receptor antagonists have insul...
Abstract—Telmisartan shows antihypertensive and several pleiotropic effects that interact with metab...
AbstractAlthough telmisartan, an angiotensin II receptor blocker (ARB), has an agonistic action for ...
Kai-Chun Cheng,1,* Yingxiao Li,1,2,* Wei-Ting Chang,2,3 Feng Yu Kuo,4 Zhih-Cherng Chen,3,5 Juei-Tang...
Antiretroviral therapy in HIV-positive patients leads to insulin resistance which is central to the ...
Selective peroxisome proliferator–activated receptor (PPAR) {gamma} modulation is a new pharmacologi...
Telmisartan is an angiotensin II receptor blocker with peroxisome proliferator-activated receptor-ga...
The AT(1) receptor blocker telmisartan (TEL) prevents diet-induced obesity. Hypothalamic lipid metab...
Obesity is a global health problem and treatment options are still insufficient. When chronically tr...
Receptores ativadores de proliferação perixossomal(PPARs) são fatores de transcrição envolvidos com ...
Abstract Background Metabolic syndrome is a cluster of common cardiovascular risk factors that inclu...
In the present study, we examined the therapeutic effects of olmesartan, an angiotensin II (Ang II) ...
Hypertension and dyslipidemia are two major risk factors for cardiovascular diseases and commonly oc...
Adipose tissue plays an important role in energy balance and metabolism and is the major target for ...
Glitazones are peroxisome proliferator-activated receptor (PPAR)-gamma agonists with powerful insuli...
AbstractEvidence has accumulated that some of the angiotensin II AT1 receptor antagonists have insul...
Abstract—Telmisartan shows antihypertensive and several pleiotropic effects that interact with metab...
AbstractAlthough telmisartan, an angiotensin II receptor blocker (ARB), has an agonistic action for ...
Kai-Chun Cheng,1,* Yingxiao Li,1,2,* Wei-Ting Chang,2,3 Feng Yu Kuo,4 Zhih-Cherng Chen,3,5 Juei-Tang...
Antiretroviral therapy in HIV-positive patients leads to insulin resistance which is central to the ...
Selective peroxisome proliferator–activated receptor (PPAR) {gamma} modulation is a new pharmacologi...
Telmisartan is an angiotensin II receptor blocker with peroxisome proliferator-activated receptor-ga...
The AT(1) receptor blocker telmisartan (TEL) prevents diet-induced obesity. Hypothalamic lipid metab...
Obesity is a global health problem and treatment options are still insufficient. When chronically tr...
Receptores ativadores de proliferação perixossomal(PPARs) são fatores de transcrição envolvidos com ...
Abstract Background Metabolic syndrome is a cluster of common cardiovascular risk factors that inclu...
In the present study, we examined the therapeutic effects of olmesartan, an angiotensin II (Ang II) ...
Hypertension and dyslipidemia are two major risk factors for cardiovascular diseases and commonly oc...